Author

Koen Sedeyn

Ghent UniversityORCID 0000-0002-1303-1629Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Organism:mouse· 2 Assay:proteomics· 2 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:protein sequence· 1 Organism:rat· 1

Frequent Co-Authors

Xavier SaelensiD· 3 shared Bert SchepensiD· 2 shared Chiara LonigroiD· 2 shared Daria FijałkowskaiD· 2 shared Dirk JochmansiD· 2 shared Hannah EeckhautiD· 2 shared Iebe RosseyiD· 2 shared Jackeline Cecilia Zavala MarchaniD· 2 shared

Activity by Year

2021-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

Xavier SaelensORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologybioRxivPreprintFeb 4, 2026

The breadth of protection mediated by anti-N2 neuraminidase antibody responses relies on cross-reactive and not cross-inhibiting antibodies

Laura Amelinck, Anouk Smet, Tine Ysenbaert…·João Paulo Portela Catani

The study shows that cross-reactive antibodies, not cross-inhibiting ones, are responsible for broad protection against heterologous HxN2 influenza viruses.

DOI 10.64898/2026.02.02.703223

mouseproteomics

𝕏 PostBluesky

MicrobiologybioRxivPreprintMar 4, 2024

Yeast-based production platform for potent and stable heavy chain-only antibodies

Chiara Lonigro, Hannah Eeckhaut, Royan Alipour Symakani…·Nico Callewaert

This paper presents a yeast-based platform for producing stable and potent heavy chain-only antibodies, demonstrating its effectiveness with an anti-SARS-CoV-2 example.

DOI 10.1101/2024.03.04.580093

yeastprotein sequence

𝕏 PostBluesky

Molecular BiologybioRxivPreprintMar 8, 2021

Drug development of an affinity enhanced, broadly neutralizing heavy chain-only antibody that restricts SARS-CoV-2 in rodents

Bert Schepens, Loes van Schie, Wim Nerinckx…·Xavier Saelens

The paper describes the development of a broadly neutralizing antibody, XVR011, effective against SARS-CoV-2 and its variants in animal models.

7 citations

mouserat

𝕏 PostBluesky